IQVIA Holdings EBITDA Margin 2011-2025 | IQV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for IQVIA Holdings (IQV) over the last 10 years. The current EBITDA margin for IQVIA Holdings as of September 30, 2025 is .
| IQVIA Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $15.90B | $3.33B | 20.96% |
| 2025-06-30 | $15.70B | $3.32B | 21.15% |
| 2025-03-31 | $15.50B | $3.33B | 21.48% |
| 2024-12-31 | $15.41B | $3.34B | 21.66% |
| 2024-09-30 | $15.32B | $3.23B | 21.06% |
| 2024-06-30 | $15.16B | $3.18B | 20.95% |
| 2024-03-31 | $15.07B | $3.17B | 21.02% |
| 2023-12-31 | $14.98B | $3.12B | 20.82% |
| 2023-09-30 | $14.86B | $3.04B | 20.45% |
| 2023-06-30 | $14.68B | $2.98B | 20.29% |
| 2023-03-31 | $14.49B | $2.92B | 20.13% |
| 2022-12-31 | $14.41B | $2.94B | 20.43% |
| 2022-09-30 | $14.31B | $2.93B | 20.49% |
| 2022-06-30 | $14.14B | $2.85B | 20.16% |
| 2022-03-31 | $14.03B | $2.76B | 19.65% |
| 2021-12-31 | $13.87B | $2.67B | 19.27% |
| 2021-09-30 | $13.54B | $2.58B | 19.09% |
| 2021-06-30 | $12.93B | $2.45B | 18.97% |
| 2021-03-31 | $12.01B | $2.19B | 18.26% |
| 2020-12-31 | $11.36B | $2.04B | 17.92% |
| 2020-09-30 | $10.96B | $1.88B | 17.17% |
| 2020-06-30 | $10.94B | $1.88B | 17.16% |
| 2020-03-31 | $11.16B | $2.00B | 17.89% |
| 2019-12-31 | $11.09B | $1.99B | 17.97% |
| 2019-09-30 | $10.88B | $2.01B | 18.50% |
| 2019-06-30 | $10.71B | $1.97B | 18.43% |
| 2019-03-31 | $10.53B | $1.93B | 18.35% |
| 2018-12-31 | $10.41B | $1.89B | 18.18% |
| 2018-09-30 | $10.25B | $1.81B | 17.69% |
| 2018-06-30 | $10.12B | $1.80B | 17.77% |
| 2018-03-31 | $9.91B | $1.76B | 17.74% |
| 2017-12-31 | $9.70B | $1.73B | 17.81% |
| 2017-09-30 | $9.46B | $1.60B | 16.92% |
| 2017-06-30 | $8.49B | $1.38B | 16.25% |
| 2017-03-31 | $7.69B | $1.15B | 14.95% |
| 2016-12-31 | $6.82B | $0.93B | 13.59% |
| 2016-09-30 | $6.06B | $0.85B | 14.02% |
| 2016-06-30 | $5.99B | $0.82B | 13.74% |
| 2016-03-31 | $5.88B | $0.83B | 14.18% |
| 2015-12-31 | $5.74B | $0.79B | 13.82% |
| 2015-09-30 | $5.63B | $0.77B | 13.63% |
| 2015-06-30 | $5.60B | $0.74B | 13.26% |
| 2015-03-31 | $5.50B | $0.72B | 13.11% |
| 2014-12-31 | $5.46B | $0.72B | 13.15% |
| 2014-09-30 | $5.43B | $0.69B | 12.66% |
| 2014-06-30 | $5.22B | $0.66B | 12.63% |
| 2014-03-31 | $5.18B | $0.62B | 11.97% |
| 2013-12-31 | $5.10B | $0.59B | 11.59% |
| 2013-09-30 | $5.00B | $0.55B | 11.06% |
| 2013-06-30 | $5.00B | $0.54B | 10.71% |
| 2013-03-31 | $4.94B | $0.53B | 10.75% |
| 2012-12-31 | $4.87B | $0.51B | 10.38% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $38.484B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.497B | 25.84 |
| Intuitive Surgical (ISRG) | United States | $196.216B | 76.77 |
| IDEXX Laboratories (IDXX) | United States | $56.495B | 56.11 |
| Edwards Lifesciences (EW) | United States | $48.884B | 32.78 |
| Alcon (ALC) | Switzerland | $38.848B | 26.25 |
| Mettler-Toledo (MTD) | United States | $29.041B | 33.98 |
| DexCom (DXCM) | United States | $26.888B | 37.06 |
| STERIS (STE) | Ireland | $24.781B | 25.58 |
| Waters (WAT) | United States | $23.350B | 30.88 |
| Hologic (HOLX) | United States | $16.680B | 17.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.086B | 0.00 |
| Penumbra (PEN) | United States | $12.195B | 85.79 |
| Globus Medical (GMED) | United States | $11.896B | 24.97 |
| Masimo (MASI) | United States | $7.589B | 24.32 |
| Glaukos (GKOS) | United States | $6.274B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.005B | 19.08 |
| Teleflex (TFX) | United States | $5.624B | 8.96 |
| TransMedics (TMDX) | United States | $4.361B | 51.67 |
| LivaNova (LIVN) | United Kingdom | $3.492B | 18.86 |
| Veracyte (VCYT) | United States | $3.337B | 38.04 |
| Alphatec Holdings (ATEC) | United States | $2.958B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.535B | 11.90 |
| Elekta AB (EKTAY) | Sweden | $2.212B | 20.69 |
| Artivion (AORT) | United States | $2.155B | 98.87 |
| PROCEPT BioRobotics (PRCT) | United States | $2.013B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.804B | 15.75 |
| UFP Technologies (UFPT) | United States | $1.657B | 21.88 |
| Tandem Diabetes Care (TNDM) | United States | $1.422B | 0.00 |
| AxoGen (AXGN) | United States | $1.383B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.290B | 0.00 |
| IRadimed (IRMD) | United States | $1.239B | 59.02 |
| Integra LifeSciences Holdings (IART) | United States | $1.094B | 5.93 |
| OPKO Health (OPK) | United States | $1.067B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.932B | 0.00 |
| SiBone (SIBN) | United States | $0.817B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.655B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.631B | 36.66 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.622B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.554B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.549B | 10.95 |
| NeuroPace (NPCE) | United States | $0.549B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.438B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.434B | 11.98 |
| Alpha Tau Medical (DRTS) | Israel | $0.421B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 61.12 |
| Semler Scientific (SMLR) | United States | $0.294B | 2.19 |
| Spectral Diagnostics (EDTXF) | Canada | $0.275B | 0.00 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| CVRx (CVRX) | United States | $0.221B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.218B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.185B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.165B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.157B | 0.00 |
| Solana (HSDT) | United States | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.106B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.088B | 0.00 |
| DarioHealth (DRIO) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.064B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.037B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |